Eisler Capital (UK)’s Medtronic MDT Stock Holding History

Eisler Capital (UK)’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,240	Closed	-$100K	–	196
2022 Q3	$100K	Buy	+1,240	New	+$111K	0.01%	135

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Eisler Capital (UK)'s MDT Position: Q4 2022 in Review

Eisler Capital (UK) sold out of Medtronic (MDT) in Q4 2022, closing a stake of 1,240 shares — an estimated $100K sold.

Eisler Capital (UK) first reported a position in MDT in Q3 2022 and held it in 1 quarter. The position peaked at $100K in Q3 2022. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

Eisler Capital (UK) reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
Eisler Capital (UK) sold 1,240 Medtronic shares in Q4 2022, an estimated $100K.
Eisler Capital (UK) first reported a position in Medtronic in Q3 2022 and held it in 1 quarter.
Eisler Capital (UK)'s Medtronic position peaked at $100K in Q3 2022.
1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Eisler Capital (UK)'s 13F filing for Q4 2022, filed 14 Feb 2023.